Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach

Cancer Statistics, 2003

Ahmedin Jemal, Thomas S. Murray, Alicia Samuels et al. · CA A Cancer Journal for Clinicians · 2003 · 3.3K citations · Full text

Medicine, Demography, Oncology +17

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2.1K citations

Medicine, Gynecology, Oncology +17

Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis

R.E. Bristow · Journal of Clinical Oncology · 2002 · 877 citations

Medicine, Oncology, Surgery +17

Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.

Griffiths Ct · PubMed · 1975 · 817 citations

Medicine, Oncology, Surgery +17

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

Mark F. Brady, Harrison Ball, Jonathan S. Berek · American Journal of Obstetrics and Gynecology · 1994 · 670 citations

Medicine, Gynecology, Surgery +16